Marta Montero

3.5k total citations
69 papers, 669 citations indexed

About

Marta Montero is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Marta Montero has authored 69 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 32 papers in Epidemiology and 22 papers in Virology. Recurrent topics in Marta Montero's work include HIV/AIDS Research and Interventions (25 papers), HIV-related health complications and treatments (22 papers) and HIV Research and Treatment (22 papers). Marta Montero is often cited by papers focused on HIV/AIDS Research and Interventions (25 papers), HIV-related health complications and treatments (22 papers) and HIV Research and Treatment (22 papers). Marta Montero collaborates with scholars based in Spain, United States and United Kingdom. Marta Montero's co-authors include José Antonio Iribarren, Hernando Knobel, José Ramón Blanco, Josep Mallolas, Joaquín Portilla, Félix Gutiérrez, Fernando Dronda, Federico Pulido, José Ramón Arribas and María Callejo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Physical Chemistry B.

In The Last Decade

Marta Montero

58 papers receiving 654 citations

Peers

Marta Montero

EPIDE

VIROL

HEPAT

Pierfrancesco Grima Italy

María Luisa Navarro Spain

Evangelo Boumis Italy

Simona Di Giambenedetto Italy

S Bevilacqua France

Ludmila Vīksna Latvia

Jason Brunetta Canada

María Isabel de José Spain

R D’Elia Italy

Monique H. Reijers Netherlands

Pierfrancesco Grima Italy

Marta Montero

234 ×0.7

178 ×0.7

EPIDE

193 ×1.0

VIROL

183 ×1.7

60 ×0.6

HEPAT

Citations per year, relative to Marta Montero Marta Montero (= 1×) peers Pierfrancesco Grima

Countries citing papers authored by Marta Montero

Since Specialization

Citations

This map shows the geographic impact of Marta Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Montero more than expected).

Fields of papers citing papers by Marta Montero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Montero. The network helps show where Marta Montero may publish in the future.

Co-authorship network of co-authors of Marta Montero

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Montero. A scholar is included among the top collaborators of Marta Montero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Montero. Marta Montero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Izquierdo, Rebeca, Alejandro Vallejo, Inés Suárez‐García, et al.. (2025). Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 274–282.

Valencia, Eulalia, Marta Montero, José Sanz, et al.. (2024). Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815). Enfermedades infecciosas y microbiologia clinica (English ed ). 43(3). 125–132.

Valencia, Eulalia, Marta Montero, José Sanz, et al.. (2024). Estudio prospectivo para la detección precoz de carcinoma pulmonar en pacientes con infección por VIH (estudio GESIDA 8815). Enfermedades Infecciosas y Microbiología Clínica. 43(3). 125–132.

Llibre, Josep M., Féderico García, José Luís Blanco, et al.. (2024). Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain. HIV Medicine. 25(8). 946–957. 1 indexed citations

Mussini, Cristina, Charles Cazanave, Eisuke Adachi, et al.. (2024). Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study. AIDS and Behavior. 29(1). 64–76. 3 indexed citations

Serrano‐Villar, Sergio, et al.. (2023). Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain. Enfermedades Infecciosas y Microbiología Clínica. 42(9). 484–491.

Gutiérrez‐Valencia, Alicia, Ana Mariño, Alexandre Pérez‐González, et al.. (2023). IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors. Frontiers in Immunology. 14. 1257725–1257725. 4 indexed citations

Astigueta, Juan, et al.. (2023). Five-Fraction Proton Therapy for the Treatment of Skull Base Chordomas and Chondrosarcomas: Early Results of a Prospective Series and Description of a Clinical Trial. Cancers. 15(23). 5579–5579. 2 indexed citations

Bernardino, José Ignacio, Belén Alejos, Javier Rodríguez-Centeno, et al.. (2023). Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV. Microorganisms. 11(7). 1818–1818. 2 indexed citations

10.

Santos, José Ramón, Peré Domingo, Joaquín Portilla, et al.. (2023). A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 10(11). ofad542–ofad542. 2 indexed citations

11.

Ruiz‐Algueró, Marta, Rebeca Izquierdo, Inés Suárez‐García, et al.. (2023). Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV. HIV Medicine. 24(6). 727–737. 1 indexed citations

12.

Palacios, Rosario, Cristina Gómez‐Ayerbe, José L. Casado, et al.. (2023). Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119. HIV Medicine. 24(8). 933–937. 3 indexed citations

13.

Serrano‐Villar, Sergio, et al.. (2023). Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(9). 484–491. 1 indexed citations

14.

Tarancón‐Díez, Laura, Itzíar Carrasco, Santiago Jiménez de Ory, et al.. (2023). Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy. Biomedicine & Pharmacotherapy. 162. 114587–114587. 1 indexed citations

15.

Koerber, Anne, et al.. (2020). Sociodemographic and behavioural determinants of early childhood caries knowledge among expectant mothers in Kuwait. European Archives of Paediatric Dentistry. 22(3). 449–458. 10 indexed citations

16.

Medrano, Luz María, Mónica Gutiérrez‐Rivas, Julià Blanco, et al.. (2018). Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy. Journal of Translational Medicine. 16(1). 343–343. 6 indexed citations

17.

Ferrando‐Martínez, Sara, Santiago Jiménez de Ory, Miguel Genebat, et al.. (2017). Thymic Function Failure Is Associated With Human Immunodeficiency Virus Disease Progression. Clinical Infectious Diseases. 64(9). 1191–1197. 28 indexed citations

18.

Arribas, José Ramón, Pierre‐Marie Girard, Roland Landman, et al.. (2015). Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial. The Lancet Infectious Diseases. 15(7). 785–792. 102 indexed citations

19.

Dronda, Fernando, Paz Sobrino‐Vegas, Ana María Caro-Murillo, et al.. (2011). Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections. Current HIV Research. 9(4). 229–236. 7 indexed citations

20.

Knobel, Hernando, et al.. (2008). Risk of side effects associated with the use of nevirapine in treatment‐naïve patients, with respect to gender and CD4 cell count. HIV Medicine. 9(1). 14–18. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact